Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Bo Ahrén

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Islets of Langerhans

Living Beings

Procedures

Glucose Tolerance Test

Disorders

Concepts & Ideas

Body Weight

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
27
Sundler, Frank
20
Winzell, Maria Sörhede
17
Larsson, Hillevi
15
Karlsson, S
14
Olsson, Tommy
13
Söderberg, Siv
10
Simonsson, Erik
9
Havel, Peter
9
Filipsson, K
8
Degerman, Eva
8
Carr, Richard
8
Holm, Cecilia
8
Lindeberg, Staffan
7
Holst, JJ
7
Eliasson, Mats

Sign-in to see all Coauthors

Publications

TOP 3
Vikman J; Ahrén B
Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets.
Guldstrand M; Ahrén B; Näslund E; Holst J J; Adamson U
Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery.
Ahrén Bo
Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Bo Ahrén (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Vikman J; Ahrén B
Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets.
Diabetes, obesity & metabolism 2009;11 Suppl 4():197-201.
2009: Guldstrand M; Ahrén B; Näslund E; Holst J J; Adamson U
Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery.
Diabetes, obesity & metabolism 2009;11(11):1027-33.
2009: Ahrén Bo
Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events.
Best practice & research. Clinical endocrinology & metabolism 2009;23(4):487-98.
2009: Lindgren Ola; Mari Andrea; Deacon Carolyn F; Carr Richard D; Winzell Maria Sörhede; Vikman Jenny; Ahrén Bo
Differential islet and incretin hormone responses in morning versus afternoon after standardized meal in healthy men.
The Journal of clinical endocrinology and metabolism 2009;94(8):2887-92.
2009: Westling Sofie; Ahrén Bo; Sunnqvist Charlotta; Träskman-Bendz Lil
Altered glucose tolerance in women with deliberate self-harm.
Psychoneuroendocrinology 2009;34(6):878-83.
2009: Ahrén B; Mari A; Fyfe C L; Tsofliou F; Sneddon A A; Wahle K W; Winzell M S; Pacini G; Williams L M
Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men.
European journal of clinical nutrition 2009;63(6):778-86.
2009: Ahrén Bo
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.
Nature reviews. Drug discovery 2009;8(5):369-85.
2009: Ahrén Bo; Schweizer Anja; Dejager Sylvie; Dunning Beth E; Nilsson Peter M; Persson Margaretha; Foley James E
Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2009;94(4):1236-43.
2009: Rengman Sofia; Weström Björn; Ahrén Bo; Pierzynowski Stefan G
Arterial gastroduodenal infusion of cholecystokinin-33 stimulates the exocrine pancreatic enzyme release via an enteropancreatic reflex, without affecting the endocrine insulin secretion in pigs.
Pancreas 2009;38(2):213-8.
2009: Jönsson Tommy; Granfeldt Yvonne; Ahrén Bo; Branell Ulla-Carin; Pålsson Gunvor; Hansson Anita; Söderström Margareta; Lindeberg Staffan
Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study.
Cardiovascular diabetology 2009;8():35.
2008: Ahrén Bo
Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes.
Expert opinion on emerging drugs 2008;13(4):593-607.
2008: Eriksson Maria A; Rask Eva; Johnson Owe; Carlström Kjell; Ahrén Bo; Eliasson Mats; Boman Kurt; Söderberg Stefan
Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2008;19(7):625-32.
2008: Carr Richard D; Larsen Marianne O; Winzell Maria Sörhede; Jelic Katarina; Lindgren Ola; Deacon Carolyn F; Ahrén Bo
Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
American journal of physiology. Endocrinology and metabolism 2008;295(4):E779-84.
2008: Dencker Magnus; Thorsson Ola; Karlsson Magnus K; Lindén Christian; Eiberg Stig; Wollmer Per; Andersen Lars Bo; Ahrén Bo
Body fat related to daily physical activity and insulin concentrations in non-diabetic children.
Clinical physiology and functional imaging 2008;28(4):211-5.
2008: Ahrén B
Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans.
Diabetologia 2008;51(6):1018-24.
2008: Ahrén Bo; Pratley Richard E; Soubt Mazin; Dunning Beth E; Foley James E
Clinical measures of islet function: usefulness to characterize defects in diabetes.
Current diabetes reviews 2008;4(2):129-45.
2008: Ahrén Bo; Winzell Maria Sörhede; Pacini Giovanni
The augmenting effect on insulin secretion by oral versus intravenous glucose is exaggerated by high-fat diet in mice.
The Journal of endocrinology 2008;197(1):181-7.
2008: Ahrén B; Foley J E
The islet enhancer vildagliptin: mechanisms of improved glucose metabolism.
International journal of clinical practice. Supplement 2008;(159):8-14.
2008: Winzell Maria Sörhede; Ahrén Bo
Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
Journal of molecular endocrinology 2008;40(2):93-100.
2008: Ahrén Bo; Sörhede Winzell Maria
Disturbed alpha-cell function in mice with beta-cell specific overexpression of human islet amyloid polypeptide.
Experimental diabetes research 2008;2008():304513.
2008: Ahrén Bo
Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin.
Vascular health and risk management 2008;4(2):383-94.
2008: Höppener J W M; Jacobs H M; Wierup N; Sotthewes G; Sprong M; de Vos P; Berger R; Sundler F; Ahrén B
Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.
Experimental diabetes research 2008;2008():697035.
2007: Ahrén Bo
[Two breakthroughs in the treatment of type 2 diabetes. Both the receptor agonist and enzyme inhibitors now available in the clinic]
Läkartidningen 2007;104(49-50):3763-4.
2007: Ahrén Bo
DPP-4 inhibitors.
Best practice & research. Clinical endocrinology & metabolism 2007;21(4):517-33.
2007: Winzell Maria Sörhede; Ahrén Bo
G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes.
Pharmacology & therapeutics 2007;116(3):437-48.
2007: Ahrén B; Pacini G; Tura A; Foley J E; Schweizer A
Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2007;39(11):826-9.
2007: Ahrén Bo
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors.
Current diabetes reports 2007;7(5):340-7.
2007: Ahrén Bo; Winzell Maria Sörhede; Wierup Nils; Sundler Frank; Burkey Bryan; Hughes Thomas E
DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
Regulatory peptides 2007;143(1-3):97-103.
2007: Lindeberg S; Jönsson T; Granfeldt Y; Borgstrand E; Soffman J; Sjöström K; Ahrén B
A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease.
Diabetologia 2007;50(9):1795-807.
2007: Winzell Maria Sörhede; Ahrén Bo
Role of VIP and PACAP in islet function.
Peptides 2007;28(9):1805-13.
2007: Lindgärde Folke; Ahrén Bo
Improved metabolic risk markers following two 6-month physical activity programs among socioeconomic marginalized women of Native American ancestry in Lima, Peru.
Diabetes care 2007;30(9):2230-2.
2007: Ahrén Bo
Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications.
Diabetes care 2007;30(6):1344-50.
2007: Mattsson Cecilia; Rask Eva; Carlström Kjell; Andersson Jonas; Eliasson Mats; Ahrén Bo; Söderberg Stefan; Olsson Tommy
Gender-specific links between hepatic 11beta reduction of cortisone and adipokines.
Obesity (Silver Spring, Md.) 2007;15(4):887-94.
2007: Ahrén Bo
Insulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects.
Diabetes care 2007;30(3):644-8.
2007: Petersen Astrid H; Laursen Torben; Ahrén Bo; Pieber Thomas R; Clauson Per; Wollmer Per
The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;30(3-4):351-7.
2007: Flodgren Erik; Olde Björn; Meidute-Abaraviciene Sandra; Winzell Maria Sörhede; Ahrén Bo; Salehi Albert
GPR40 is expressed in glucagon producing cells and affects glucagon secretion.
Biochemical and biophysical research communications 2007;354(1):240-5.
2007: Gram Dorte X; Ahrén Bo; Nagy Istvan; Olsen Uffe B; Brand Christian L; Sundler Frank; Tabanera René; Svendsen Ove; Carr Richard D; Santha Peter; Wierup Nils; Hansen Anker J
Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes.
The European journal of neuroscience 2007;25(1):213-23.
2007: Winzell Maria Sörhede; Magnusson Caroline; Ahrén Bo
Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice.
Metabolism: clinical and experimental 2007;56(1):122-8.
2006: Lindgärde Folke; Vessby Bengt; Ahrén Bo
Serum cholesteryl fatty acid composition and plasma glucose concentrations in Amerindian women.
The American journal of clinical nutrition 2006;84(5):1009-13.
2006: Ahrén Bo
[Clinical research must be based on teaming physician and researcher]
Läkartidningen 2006;103(36):2575.
2006: Dencker Magnus; Thorsson Ola; Karlsson Magnus K; Lindén Christian; Wollmer Per; Ahrén Bo
Leptin is closely related to body fat in prepubertal children aged 8-11 years.
Acta paediatrica (Oslo, Norway : 1992) 2006;95(8):975-9.
2006: Gunnarsson P Thomas; Winzell Maria Sörhede; Deacon Carolyn F; Larsen Marianne O; Jelic Katarina; Carr Richard D; Ahrén Bo
Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice.
Endocrinology 2006;147(7):3173-80.
2006: Ahrén B; Pacini G
A novel approach to assess insulin sensitivity reveals no increased insulin sensitivity in mice with a dominant-negative mutant hepatocyte nuclear factor-1alpha.
American journal of physiology. Regulatory, integrative and comparative physiology 2006;291(1):R131-7.
2006: Walz Helena A; Härndahl Linda; Wierup Nils; Zmuda-Trzebiatowska Emilia; Svennelid Fredrik; Manganiello Vincent C; Ploug Thorkil; Sundler Frank; Degerman Eva; Ahrén Bo; Holst Lena Stenson
Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B.
The Journal of endocrinology 2006;189(3):629-41.
2006: Sandqvist M; Johanson E H; Ahrén B; Axelsen M; Schmelz M; Smith U; Jansson P-A
Postprandial interstitial insulin concentrations in type 2 diabetes relatives.
European journal of clinical investigation 2006;36(6):383-8.
2006: García Maria C; Wernstedt Ingrid; Berndtsson Anna; Enge Maria; Bell Michal; Hultgren Olof; Horn Michael; Ahrén Bo; Enerback Sven; Ohlsson Claes; Wallenius Ville; Jansson John-Olov
Mature-onset obesity in interleukin-1 receptor I knockout mice.
Diabetes 2006;55(5):1205-13.
2006: Follin Cecilia; Thilén Ulf; Ahrén Bo; Erfurth Eva Marie
Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
The Journal of clinical endocrinology and metabolism 2006;91(5):1872-5.
2006: Ahrén Bo
Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties.
Expert opinion on investigational drugs 2006;15(4):431-42.
2006: Xu Ning; Nilsson-Ehle Peter; Ahrén Bo
Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin.
Biochemical and biophysical research communications 2006;342(4):1174-7.
2006: Ahrén Bo
The insulin response to gastric glucose is reduced in PAC1 and GRP receptor gene deleted mice.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2006;16 Suppl 1():S17-21.
2006: Winzell Maria Sörhede; Ström Kristoffer; Holm Cecilia; Ahrén Bo
Glucose-stimulated insulin secretion correlates with beta-cell lipolysis.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2006;16 Suppl 1():S11-6.
2006: Ahrén Bo; Pacini Giovanni
Contributions from the first SICOD (Swedish-Italian Cooperation on Diabetes Research) meeting, Stockholm, Sweden, October 2004.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2006;16 Suppl 1():S1-2.
2006: Bülow Birgitta; Jansson Svante; Juhlin Claes; Steen Lars; Thorén Marja; Wahrenberg Hans; Valdemarsson Stig; Wängberg Bo; Ahrén Bo
Adrenal incidentaloma - follow-up results from a Swedish prospective study.
European journal of endocrinology / European Federation of Endocrine Societies 2006;154(3):419-23.
2006: Xu Ning; Ahrén Bo; Jiang Jingting; Nilsson-Ehle Peter
Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells.
Biochimica et biophysica acta 2006;1761(2):256-60.
2006: Winzell Maria Sörhede; Pacini Giovanni; Ahrén Bo
Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice.
American journal of physiology. Endocrinology and metabolism 2006;290(2):E347-54.
2006: Linderoth Ann; Prykhod'ko Olena; Ahrén Bo; Fåk Frida; Pierzynowski Stefan G; Weström Björn R
Binding and the effect of the red kidney bean lectin, phytohaemagglutinin, in the gastrointestinal tract of suckling rats.
The British journal of nutrition 2006;95(1):105-15.
2006: Ahrén B
Glucagon secretion in relation to insulin sensitivity in healthy subjects.
Diabetologia 2006;49(1):117-22.
2006: Jönsson Tommy; Ahrén Bo; Pacini Giovanni; Sundler Frank; Wierup Nils; Steen Stig; Sjöberg Trygve; Ugander Martin; Frostegård Johan; Göransson Leif; Lindeberg Staffan
A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs.
Nutrition & metabolism 2006;3():39.
2005: Gram Dorte X; Hansen Anker J; Wilken Michael; Elm Torben; Svendsen Ove; Carr Richard D; Ahrén Bo; Brand Christian L
Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(6):963-9.
2005: Sörhede Winzell Maria; Magnusson Caroline; Ahrén Bo
The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice.
Regulatory peptides 2005;131(1-3):12-7.
2005: Ahrén Bo; Sörhede Winzell Maria; Burkey Bryan; Hughes Thomas E
Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice.
European journal of pharmacology 2005;521(1-3):164-8.
2005: Ahrén B; Thomaseth K; Pacini G
Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice.
Diabetologia 2005;48(10):2140-6.
2005: Mari Andrea; Ahrén Bo; Pacini Giovanni
Assessment of insulin secretion in relation to insulin resistance.
Current opinion in clinical nutrition and metabolic care 2005;8(5):529-33.
2005: Ahrén Bo; Pacini Giovanni; Foley James E; Schweizer Anja
Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year.
Diabetes care 2005;28(8):1936-40.
2005: Borch Kurt; Ahrén Bo; Ahlman Håkan; Falkmer Sture; Granérus Göran; Grimelius Lars
Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type.
Annals of surgery 2005;242(1):64-73.
2005: Moesgaard Sophia G; Brand Christian L; Sturis Jeppe; Ahrén Bo; Wilken Michael; Fleckner Jan; Carr Richard D; Svendsen Ove; Hansen Anker J; Gram Dorte X
Sensory nerve inactivation by resiniferatoxin improves insulin sensitivity in male obese Zucker rats.
American journal of physiology. Endocrinology and metabolism 2005;288(6):E1137-45.
2005: Ahrén B
Type 2 diabetes, insulin secretion and beta-cell mass.
Current molecular medicine 2005;5(3):275-86.
2005: Sandqvist Madeléne; Nyberg Gunnar; Hammarstedt Ann; Klintland Natalia; Gogg Silvia; Caidahl Kenneth; Ahrén Bo; Smith Ulf; Jansson Per-Anders
Low adipocyte IRS-1 protein expression is associated with an increased arterial stiffness in non-diabetic males.
Atherosclerosis 2005;180(1):119-25.
2005: Ahrén B
What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?
Diabetologia 2005;48(4):605-7.
2005: Ahrén Bo; Hughes Thomas E
Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice.
Endocrinology 2005;146(4):2055-9.
2005: Ahrén Bo
[New strategy in type 2 diabetes tested in clinical trials. Glucagon-like peptide 1 (GLP-1) affects basic caused of the disease]
Läkartidningen 2005;102(8):545-9.
2005: Gram Dorte X; Hansen Anker J; Deacon Carolyn F; Brand Christian L; Ribel Ulla; Wilken Michael; Carr Richard D; Svendsen Ove; Ahrén Bo
Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV.
European journal of pharmacology 2005;509(2-3):211-7.
2005: Olsson Bob; Bohlooly-Y Mohammad; Fitzgerald Sharyn M; Frick Fredrik; Ljungberg Anna; Ahrén Bo; Törnell Jan; Bergström Göran; Oscarsson Jan
Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet.
Endocrinology 2005;146(2):920-30.
2005: Akesson Lina; Ahrén Bo; Edgren Gudrun; Degerman Eva
VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Endocrinology 2005;146(2):744-50.
2005: Ahrén B; Pacini G
Islet adaptation to insulin resistance: mechanisms and implications for intervention.
Diabetes, obesity & metabolism 2005;7(1):2-8.
2005: Bohlooly-Y Mohammad; Olsson Bob; Bruder Carl E G; Lindén Daniel; Sjögren Klara; Bjursell Mikael; Egecioglu Emil; Svensson Lennart; Brodin Peter; Waterton John C; Isaksson Olle G P; Sundler Frank; Ahrén Bo; Ohlsson Claes; Oscarsson Jan; Törnell Jan
Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia.
Diabetes 2005;54(1):51-62.
2005: Jönsson Tommy; Olsson Stefan; Ahrén Bo; Bøg-Hansen Thorkild C; Dole Anita; Lindeberg Staffan
Agrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance?
BMC endocrine disorders 2005;5():10.
2005: Mei Jie; Yu Shukun; Ahrén Bo
A 90-day toxicological evaluation of 1,5-anhydro-d-fructose in Sprague-Dawley rats.
Drug and chemical toxicology 2005;28(3):263-72.
2005: Evilevitch L; Pierzynowski S G; Linderoth A; Ahrén B; Erlanson-Albertsson Ch; Podgurniak M; Weström B R
Three-day enteral exposure to a red kidney bean lectin preparation enhances the pancreatic response to CCK stimulation in suckling pigs.
Biology of the neonate 2005;87(1):20-5.
2004: Westling Sofie; Ahrén Bo; Träskman-Bendz Lil; Westrin Asa
High CSF-insulin in violent suicide attempters.
Psychiatry research 2004;129(3):249-55.
2004: Bülow Birgitta; Link Katarina; Ahrén Bo; Nilsson Ann-Sofie; Erfurth Eva Marie
Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
Clinical endocrinology 2004;61(6):683-91.
2004: Ahrén Bo; Gomis Ramon; Standl Eberhard; Mills David; Schweizer Anja
Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes.
Diabetes care 2004;27(12):2874-80.
2004: Winzell Maria Sörhede; Pacini Giovanni; Wollheim Claes B; Ahrén Bo
Beta-cell-targeted expression of a dominant-negative mutant of hepatocyte nuclear factor-1alpha in mice: diabetes model with beta-cell dysfunction partially rescued by nonglucose secretagogues.
Diabetes 2004;53 Suppl 3():S92-6.
2004: Winzell Maria Sörhede; Ahrén Bo
The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.
Diabetes 2004;53 Suppl 3():S215-9.
2004: Nyström Thomas; Gutniak Mark K; Zhang Qimin; Zhang Fan; Holst Jens Juul; Ahrén Bo; Sjöholm Ake
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
American journal of physiology. Endocrinology and metabolism 2004;287(6):E1209-15.
2004: Ahrén B; Schmitz O
GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2004;36(11-12):867-76.
2004: Ahrén B
GLP-1 and extra-islet effects.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2004;36(11-12):842-5.
2004: Sörhede Winzell M; Ahrén B
Glucagon-like peptide-1 and islet lipolysis.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2004;36(11-12):795-803.
2004: Xu Ning; Nilsson-Ehle Peter; Ahrén Bo
Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects.
The Journal of nutritional biochemistry 2004;15(10):579-82.
2004: Link Katarina; Moëll Christian; Garwicz Stanislaw; Cavallin-Ståhl Eva; Björk Jonas; Thilén Ulf; Ahrén Bo; Erfurth Eva Marie
Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
The Journal of clinical endocrinology and metabolism 2004;89(10):5003-12.
2004: Lindgärde Folke; Widén Iréne; Gebb Miriam; Ahrén Bo
Traditional versus agricultural lifestyle among Shuar women of the Ecuadorian Amazon: effects on leptin levels.
Metabolism: clinical and experimental 2004;53(10):1355-8.
2004: Yu Shukun; Mei Jie; Ahrén Bo
Basic toxicology and metabolism studies of 1,5-anhydro-D-fructose using bacteria, cultured mammalian cells, and rodents.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2004;42(10):1677-86.
2004: Degerman Eva; Manganiello Vincent; Holst Jens J; Ahrén Bo
Milrinone efficiently potentiates insulin secretion induced by orally but not intravenously administered glucose in C57BL6J mice.
European journal of pharmacology 2004;498(1-3):319-23.
2004: Xu Ning; Nilsson-Ehle Peter; Hurtig Maria; Ahrén Bo
Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo.
Biochemical and biophysical research communications 2004;321(4):916-21.
2004: Deacon Carolyn F; Ahrén Bo; Holst Jens J
Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?
Expert opinion on investigational drugs 2004;13(9):1091-102.
2004: Winzell Maria Sörhede; Nogueiras Rubén; Dieguez Carlos; Ahrén Bo
Dual action of adiponectin on insulin secretion in insulin-resistant mice.
Biochemical and biophysical research communications 2004;321(1):154-60.
2004: Moesgaard Sophia G; Ahrén Bo; Carr Richard D; Gram Dorte X; Brand Christian L; Sundler Frank
Effects of high-fat feeding and fasting on ghrelin expression in the mouse stomach.
Regulatory peptides 2004;120(1-3):261-7.
2004: Westling Sofie; Ahrén Bo; Träskman-Bendz Lil; Westrin Asa
Low CSF leptin in female suicide attempters with major depression.
Journal of affective disorders 2004;81(1):41-8.
2004: Ahrén Bo; Pacini Giovanni; Wynick David; Wierup Nils; Sundler Frank
Loss-of-function mutation of the galanin gene is associated with perturbed islet function in mice.
Endocrinology 2004;145(7):3190-6.
2004: Rolin Bidda; Deacon Carolyn F; Carr Richard D; Ahrén Bo
The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice.
European journal of pharmacology 2004;494(2-3):283-8.
2004: Rask E; Olsson T; Söderberg S; Holst Jj J j; Tura A; Pacini G; Ahrén B
Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
Metabolism: clinical and experimental 2004;53(5):624-31.
2004: Ahrén Bo; Landin-Olsson Mona; Jansson Per-Anders; Svensson Maria; Holmes David; Schweizer Anja
Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2004;89(5):2078-84.
2004: Warensjö Eva; Jansson Jan-Håkan; Berglund Lars; Boman Kurt; Ahrén Bo; Weinehall Lars; Lindahl Bernt; Hallmans Göran; Vessby Bengt
Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study.
The British journal of nutrition 2004;91(4):635-42.
2004: Härndahl Linda; Wierup Nils; Enerbäck Sven; Mulder Hindrik; Manganiello Vincent C; Sundler Frank; Degerman Eva; Ahrén Bo; Holst Lena Stenson
Beta-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology.
The Journal of biological chemistry 2004;279(15):15214-22.
2004: Lindeberg S; Cordain L; Råstam L; Ahrén B
Serum uric acid in traditional Pacific Islanders and in Swedes.
Journal of internal medicine 2004;255(3):373-8.
2004: Thøgersen Anna M; Söderberg Stefan; Jansson Jan-Håkan; Dahlén Gösta; Boman Kurt; Nilsson Torbjörn K; Lindahl Bernt; Weinehall Lars; Stenlund Hans; Lundberg Vivan; Johnson Owe; Ahrén Bo; Hallmans Göran
Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2004;11(1):33-40.
2004: Ahrén Bo; Pacini Giovanni
Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies.
European journal of endocrinology / European Federation of Endocrine Societies 2004;150(2):97-104.
2004: Ahrén Bo
Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice.
American journal of physiology. Regulatory, integrative and comparative physiology 2004;286(2):R269-72.
2004: Mulder Hindrik; Yang Shumin; Winzell Maria Sörhede; Holm Cecilia; Ahrén Bo
Inhibition of lipase activity and lipolysis in rat islets reduces insulin secretion.
Diabetes 2004;53(1):122-8.
2004: Lindgärde Folke; Ercilla Miyaray Benavente; Correa Laura Retamozo; Ahrén Bo
Body adiposity, insulin, and leptin in subgroups of Peruvian Amerindians.
High altitude medicine & biology 2004;5(1):27-31.
2003: Akesson Lina; Ahrén Bo; Manganiello Vincent C; Holst Lena Stenson; Edgren Gudrun; Degerman Eva
Dual effects of pituitary adenylate cyclase-activating polypeptide and isoproterenol on lipid metabolism and signaling in primary rat adipocytes.
Endocrinology 2003;144(12):5293-9.
2003: Larsson Hillevi; Berglund Göran; Ahrén Bo
Insulin sensitivity, insulin secretion, and glucose tolerance versus intima-media thickness in nondiabetic postmenopausal women.
The Journal of clinical endocrinology and metabolism 2003;88(10):4791-7.
2003: Ahrén Bo; Holst Jens J; Mari Andrea
Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans.
Diabetes care 2003;26(10):2860-4.
2003: Bülow B; Ahrén B; Fisker S; Dehlin O; Hagberg B; Jensen E; Svensson T; Samuelsson G; Erfurth E M
The gender differences in growth hormone-binding protein and leptin persist in 80-year-old men and women and is not caused by sex hormones.
Clinical endocrinology 2003;59(4):482-6.
2003: Ahrén Bo
Gut peptides and type 2 diabetes mellitus treatment.
Current diabetes reports 2003;3(5):365-72.
2003: Huang Xudong; Vaag Allan; Carlsson Emma; Hansson Mona; Ahrén Bo; Groop Leif
Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes.
Diabetes 2003;52(9):2411-8.
2003: Ahrén B; Havel P J; Pacini G; Cianflone K
Acylation stimulating protein stimulates insulin secretion.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2003;27(9):1037-43.
2003: Mulder Hindrik; Sörhede-Winzell Maria; Contreras Juan Antonio; Fex Malin; Ström Kristoffer; Ploug Thorkil; Galbo Henrik; Arner Peter; Lundberg Cecilia; Sundler Frank; Ahrén Bo; Holm Cecilia
Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact.
The Journal of biological chemistry 2003;278(38):36380-8.
2003: Olsson Bob; Bohlooly-Y Mohammad; Brusehed Ola; Isaksson Olle G P; Ahrén Bo; Olofsson Sven-Olof; Oscarsson Jan; Törnell Jan
Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes.
American journal of physiology. Endocrinology and metabolism 2003;285(3):E504-11.
2003: Winzell Maria Sörhede; Svensson Håkan; Enerbäck Sven; Ravnskjaer Kim; Mandrup Susanne; Esser Victoria; Arner Peter; Alves-Guerra Marie-Clotilde; Miroux Bruno; Sundler Frank; Ahrén Bo; Holm Cecilia
Pancreatic beta-cell lipotoxicity induced by overexpression of hormone-sensitive lipase.
Diabetes 2003;52(8):2057-65.
2003: Guldstrand Marie; Ahrén Bo; Wredling Regina; Backman Lars; Lins Per Eric; Adamson Ulf
Alteration of the counterregulatory responses to insulin-induced hypoglycemia and of cognitive function after massive weight reduction in severely obese subjects.
Metabolism: clinical and experimental 2003;52(7):900-7.
2003: Huang Xudong; Hansson Mona; Laurila Esa; Ahrén Bo; Groop Leif
Fat feeding impairs glycogen synthase activity in mice without effects on its gene expression.
Metabolism: clinical and experimental 2003;52(5):535-9.
2003: Reimer Martina Kvist; Mokshagundam Sri Prakash; Wyler Karen; Sundler Frank; Ahrén Bo; Stagner John I
Local growth factors are beneficial for the autonomic reinnervation of transplanted islets in rats.
Pancreas 2003;26(4):392-7.
2003: Winzell Maria Sörhede; Holm Cecilia; Ahrén Bo
Downregulation of islet hormone-sensitive lipase during long-term high-fat feeding.
Biochemical and biophysical research communications 2003;304(2):273-8.
2003: Wong H Y; Ahrén B; Lips C J M; Höppener J W M; Sundler F
Postnatally disturbed pancreatic islet cell distribution in human islet amyloid polypeptide transgenic mice.
Regulatory peptides 2003;113(1-3):89-94.
2003: Portela-Gomes Guida Maria; Lukinius Agneta; Ljungberg Otto; Efendic Suad; Ahrén Bo; Abdel-Halim Samy M
PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas. Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets.
Regulatory peptides 2003;113(1-3):31-9.
2003: Ahrén Bo
[Reclaim the clinical research--proposal to an action plan]
Läkartidningen 2003;100(15):1361.
2003: Ahrén Bo; Thorsson Ola
Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man.
The Journal of clinical endocrinology and metabolism 2003;88(3):1264-70.
2003: Reimer Martina Kvist; Pacini Giovanni; Ahrén Bo
Dose-dependent inhibition by ghrelin of insulin secretion in the mouse.
Endocrinology 2003;144(3):916-21.
2003: Guldstrand Marie; Ahrén Bo; Adamson Ulf
Improved beta-cell function after standardized weight reduction in severely obese subjects.
American journal of physiology. Endocrinology and metabolism 2003;284(3):E557-65.
2003: Sayeed Mohammed Abu; Azad Khan Abul Kalam; Mahtab Hajera; Ahsan Khandaker Abdul; Banu Akhtar; Khanam Parvin Akter; Ahrén Bo
Leptin is reduced in lean subjects with type 2 diabetes in bangladesh.
Diabetes care 2003;26(2):547.
2003: Lindeberg S; Ahrén B; Nilsson A; Cordain L; Nilsson-Ehle P; Vessby B
Determinants of serum triglycerides and high-density lipoprotein cholesterol in traditional Trobriand Islanders: the Kitava Study.
Scandinavian journal of clinical and laboratory investigation 2003;63(3):175-80.
2003: Söderberg Stefan; Stegmayr Birgitta; Ahlbeck-Glader Christine; Slunga-Birgander Lisbeth; Ahrén Bo; Olsson Tommy
High leptin levels are associated with stroke.
Cerebrovascular diseases (Basel, Switzerland) 2003;15(1-2):63-9.
2002: Höppener Jo W M; Nieuwenhuis Maria G; Vroom Thea M; Ahrén Bo; Lips Cees J M
Role of islet amyloid in type 2 diabetes mellitus: consequence or cause?
Molecular and cellular endocrinology 2002;197(1-2):205-12.
2002: Johansson A; Ahrén B; Forsberg H; Olsson T
Testosterone and diurnal rhythmicity of leptin, TNF-alpha and TNF-II receptor in insulin-resistant myotonic dystrophy patients.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(10):1386-92.
2002: Persson Kristin; Pacini Giovanni; Sundler Frank; Ahrén Bo
Islet function phenotype in gastrin-releasing peptide receptor gene-deficient mice.
Endocrinology 2002;143(10):3717-26.
2002: Ahrén Bo; Pacini Giovanni
Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice.
American journal of physiology. Endocrinology and metabolism 2002;283(4):E738-44.
2002: Härndahl Linda; Jing Xing-Jun; Ivarsson Rosita; Degerman Eva; Ahrén Bo; Manganiello Vincent C; Renström Erik; Holst Lena Stenson
Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin.
The Journal of biological chemistry 2002;277(40):37446-55.
2002: Bülow B; Ahrén B;
Adrenal incidentaloma--experience of a standardized diagnostic programme in the Swedish prospective study.
Journal of internal medicine 2002;252(3):239-46.
2002: Söderberg S; Ahrén B; Eliasson M; Dinesen B; Olsson T
The association between leptin and proinsulin is lost with central obesity.
Journal of internal medicine 2002;252(2):140-8.
2002: Persson K; Ahrén B
The neuropeptide PACAP contributes to the glucagon response to insulin-induced hypoglycaemia in mice.
Acta physiologica Scandinavica 2002;175(1):25-8.
2002: Reimer M Kvist; Holst J J; Ahrén B
Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.
European journal of endocrinology / European Federation of Endocrine Societies 2002;146(5):717-27.
2002: Ahrén Bo; Simonsson Erik; Larsson Hillevi; Landin-Olsson Mona; Torgeirsson Hlin; Jansson Per-Anders; Sandqvist Madeléne; Båvenholm Peter; Efendic Suad; Eriksson Jan W; Dickinson Sheila; Holmes David
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
Diabetes care 2002;25(5):869-75.
2002: Kvist-Reimer Martina; Sundler Frank; Ahrén Bo
Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice.
Cell and tissue research 2002;307(2):203-9.
2002: Ahrén Bo; Larsson Hillevi
Quantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women.
Diabetes 2002;51 Suppl 1():S202-11.
2002: Reimer Martina Kvist; Ahrén Bo
Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice.
Diabetes 2002;51 Suppl 1():S138-43.
2002: Zaina Silvio; Pettersson Linda; Ahrén Bo; Brånén Lena; Hassan A Bassim; Lindholm Marie; Mattsson Ragnar; Thyberg Johan; Nilsson Jan
Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model.
The Journal of biological chemistry 2002;277(6):4505-11.
2002: Wallenius Ville; Wallenius Kristina; Ahrén Bo; Rudling Mats; Carlsten Hans; Dickson Suzanne L; Ohlsson Claes; Jansson John-Olov
Interleukin-6-deficient mice develop mature-onset obesity.
Nature medicine 2002;8(1):75-9.
2002: Ahrén Bo; Taborsky Gerald J; Havel Peter J
Differential impairment of glucagon responses to hypoglycemia, neuroglycopenia, arginine, and carbachol in alloxan-diabetic mice.
Metabolism: clinical and experimental 2002;51(1):12-9.
2002: Karlsson Sven; Scheurink Anton J W; Ahrén Bo
Gender difference in the glucagon response to glucopenic stress in mice.
American journal of physiology. Regulatory, integrative and comparative physiology 2002;282(1):R281-8.
2001: Bülow B; Ahrén B; Erfurth E M
Increased leptin and tumour necrosis factor alpha per unit fat mass in hypopituitary women without growth hormone treatment.
European journal of endocrinology / European Federation of Endocrine Societies 2001;145(6):737-42.
2001: Ahrén B; Larsson H
Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations.
Diabetologia 2001;44(11):1998-2003.
2001: Winzell M S; Svensson H; Arner P; Ahrén B; Holm C
The expression of hormone-sensitive lipase in clonal beta-cells and rat islets is induced by long-term exposure to high glucose.
Diabetes 2001;50(10):2225-30.
2001: Rask E; Olsson T; Söderberg S; Johnson O; Seckl J; Holst J J; Ahrén B;
Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.
Diabetes care 2001;24(9):1640-5.
2001: Filipsson K; Kvist-Reimer M; Ahrén B
The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function.
Diabetes 2001;50(9):1959-69.
2001: Sjögren K; Wallenius K; Liu J L; Bohlooly-Y M; Pacini G; Svensson L; Törnell J; Isaksson O G; Ahrén B; Jansson J O; Ohlsson C
Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism.
Diabetes 2001;50(7):1539-45.
2001: Lindeberg S; Söderberg S; Ahrén B; Olsson T
Large differences in serum leptin levels between nonwesternized and westernized populations: the Kitava study.
Journal of internal medicine 2001;249(6):553-8.
2001: Ahrén B; Holst J J
The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia.
Diabetes 2001;50(5):1030-8.
2001: Guenifi A; Simonsson E; Karlsson S; Ahrén B; Abdel-Halim S M
Carbachol restores insulin release in diabetic GK rat islets by mechanisms largely involving hydrolysis of diacylglycerol and direct interaction with the exocytotic machinery.
Pancreas 2001;22(2):164-71.
2001: Karlsson S; Ostlund B; Myrsén-Axcrona U; Sundler F; Ahrén B
Beta cell adaptation to dexamethasone-induced insulin resistance in rats involves increased glucose responsiveness but not glucose effectiveness.
Pancreas 2001;22(2):148-56.
2001: Söderberg S; Ahrén B; Eliasson M; Dinesen B; Brismar K; Olsson T
Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women.
European journal of endocrinology / European Federation of Endocrine Societies 2001;144(3):283-90.
2001: Lindgärde F; Söderberg S; Olsson T; Ercilla M B; Correa L R; Ahrén B
Overweight is associated with lower serum leptin in Peruvian Indian than in Caucasian women: A dissociation contributing to low blood pressure?
Metabolism: clinical and experimental 2001;50(3):325-9.
2001: Ahrén B
Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice.
Acta physiologica Scandinavica 2001;171(2):161-7.
2001: Kölby L; Bernhardt P; Ahlman H; Wängberg B; Johanson V; Wigander A; Forssell-Aronsson E; Karlsson S; Ahrén B; Stenman G; Nilsson O
A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake.
The American journal of pathology 2001;158(2):745-55.
2001: Söderberg S; Olsson T; Eliasson M; Johnson O; Brismar K; Carlström K; Ahrén B
A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adiposity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2001;25(1):98-105.
2001: Karlsson S; Sundler F; Ahrén B
Direct cytoplasmic CA(2+) responses to gastrin-releasing peptide in single beta cells.
Biochemical and biophysical research communications 2001;280(3):610-4.
2001: Guenifi A; Ahrén B; Abdel-Halim S M
Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro.
Pancreas 2001;22(1):58-64.
2000: Ahrén B; Baldwin R M; Havel P J
Pharmacokinetics of human leptin in mice and rhesus monkeys.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(12):1579-85.
2000: Persson K; Gingerich R L; Nayak S; Wada K; Wada E; Ahrén B
Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice.
American journal of physiology. Endocrinology and metabolism 2000;279(5):E956-62.
2000: Larsson H; Lindgärde F; Berglund G; Ahrén B
Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study.
Diabetologia 2000;43(10):1224-8.
2000: Ahrén B; Magrum L J; Havel P J; Greene S F; Phinney S D; Johnson P R; Stern J S
Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat.
Obesity research 2000;8(6):475-80.
2000: Johansson A; Carlström K; Ahrén B; Cederquist K; Krylborg E; Forsberg H; Olsson T
Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy.
The Journal of clinical endocrinology and metabolism 2000;85(9):3169-76.
2000: Ahrén B; Holst J J; Mårtensson H; Balkan B
Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.
European journal of pharmacology 2000;404(1-2):239-45.
2000: Ahrén B
Diurnal variation in circulating leptin is dependent on gender, food intake and circulating insulin in mice.
Acta physiologica Scandinavica 2000;169(4):325-31.
2000: Filipsson K; Holst J J; Ahrén B
PACAP contributes to insulin secretion after gastric glucose gavage in mice.
American journal of physiology. Regulatory, integrative and comparative physiology 2000;279(2):R424-32.
2000: Höppener J W; Ahrén B; Lips C J
Islet amyloid and type 2 diabetes mellitus.
The New England journal of medicine 2000;343(6):411-9.
2000: Simonsson E; Karlsson S; Ahrén B
Islet phospholipase A(2) activation is potentiated in insulin resistant mice.
Biochemical and biophysical research communications 2000;272(2):539-43.
2000: Ahrén B; Holst J J; Yu S
1,5-Anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice.
European journal of pharmacology 2000;397(1):219-25.
2000: Larsson H; Ahrén B
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
Diabetes care 2000;23(5):650-7.
2000: Ahrén B
Autonomic regulation of islet hormone secretion--implications for health and disease.
Diabetologia 2000;43(4):393-410.
2000: Mulder H; Gebre-Medhin S; Betsholtz C; Sundler F; Ahrén B
Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes.
American journal of physiology. Endocrinology and metabolism 2000;278(4):E684-91.
2000: Ahrén B; Holst J J; Efendic S
Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2000;85(3):1043-8.
2000: Simonsson E; Karlsson S; Ahrén B
The cyclic AMP-protein kinase A pathway restrains islet phospholipase A(2) activation.
Biochemical and biophysical research communications 2000;269(1):242-6.
2000: Simonsson E; Ahrén B
Phospholipase A2 and its potential regulation of islet function.
International journal of pancreatology : official journal of the International Association of Pancreatology 2000;27(1):1-11.
2000: Larsson H; Ahrén B
Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women.
Diabetologia 2000;43(2):194-202.
2000: Johansson A; Ahrén B; Näsman B; Carlström K; Olsson T
Cortisol axis abnormalities early after stroke--relationships to cytokines and leptin.
Journal of internal medicine 2000;247(2):179-87.
2000: Janciauskiene S; Ahrén B
Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines.
Biochemical and biophysical research communications 2000;267(2):619-25.
2000: Filipsson K; Ahrén B
PACAP27 sensitizes glucose induced insulin secretion in INS-1 cells.
Annals of the New York Academy of Sciences 2000;921():456-9.
2000: Ahrén B; Filipsson K
The effects of PACAP on insulin secretion and glucose disposal are altered by adrenalectomy in mice.
Annals of the New York Academy of Sciences 2000;921():251-8.
1999: al-Amin A N; Ahrén B
Relation between malnutrition and development of diabetes mellitus.
International journal of pancreatology : official journal of the International Association of Pancreatology 1999;26(3):125-30.
1999: Ahrén B; Pacini G
Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.
The American journal of physiology 1999;277(6 Pt 1):E996-E1004.
1999: Söderberg S; Ahrén B; Jansson J H; Johnson O; Hallmans G; Asplund K; Olsson T
Leptin is associated with increased risk of myocardial infarction.
Journal of internal medicine 1999;246(4):409-18.
1999: Lindeberg S; Eliasson M; Lindahl B; Ahrén B
Low serum insulin in traditional Pacific Islanders--the Kitava Study.
Metabolism: clinical and experimental 1999;48(10):1216-9.
1999: Ahrén B; Havel P J
Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells).
The American journal of physiology 1999;277(4 Pt 2):R959-66.
1999: Larsson H; Ahrén B
Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity.
Diabetologia 1999;42(8):936-43.
1999: Larsson H; Daugaard J R; Kiens B; Richter E A; Ahrén B
Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance.
Diabetes care 1999;22(8):1330-8.
1999: Ahrén B; Sauerberg P; Thomsen C
Increased insulin secretion and normalization of glucose tolerance by cholinergic agonism in high fat-fed mice.
The American journal of physiology 1999;277(1 Pt 1):E93-102.
1999: Ahrén B; Havel P J
Leptin increases circulating glucose, insulin and glucagon via sympathetic neural activation in fasted mice.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1999;23(6):660-5.
1999: Larsson H; Ahrén B
Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.
The Journal of clinical endocrinology and metabolism 1999;84(6):2068-74.
1999: Al Rayyes O; Ahrén B; Florén C H
Enhancement of low density lipoprotein catabolism by non-steroidal anti-inflammatory drugs in cultured HepG2 cells.
European journal of pharmacology 1999;372(3):311-8.
1999: Söderberg S; Olsson T; Eliasson M; Johnson O; Ahrén B
Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women.
Journal of internal medicine 1999;245(5):533-43.
1999: Höppener J W; Oosterwijk C; Nieuwenhuis M G; Posthuma G; Thijssen J H; Vroom T M; Ahrén B; Lips C J
Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
Diabetologia 1999;42(4):427-34.
1999: Myrsén-Axcrona U; Ahrén B; Sundler F
Modulatory role of adrenergic nerves on dexamethasone-induced islet cell NPY expression in the rat: evidence from chemical sympathectomy.
Pancreas 1999;18(2):180-8.
1999: Filipsson K; Sundler F; Ahrén B
PACAP is an islet neuropeptide which contributes to glucose-stimulated insulin secretion.
Biochemical and biophysical research communications 1999;256(3):664-7.
1999: Ahrén B
Plasma leptin and insulin in C57BI/6J mice on a high-fat diet: relation to subsequent changes in body weight.
Acta physiologica Scandinavica 1999;165(2):233-40.
1999: Söderberg S; Ahrén B; Stegmayr B; Johnson O; Wiklund P G; Weinehall L; Hallmans G; Olsson T
Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort.
Stroke; a journal of cerebral circulation 1999;30(2):328-37.
1999: Larsson H; Ahrén B
Smoking habits and circulating leptin in postmenopausal non-obese women.
Diabetes, obesity & metabolism 1999;1(1):57-9.
1999: Guldstrand M; Backman L; Adamson U; Lins P E; Ahrén B
Lowering of circulating insulin and leptin is closely associated following weight reduction after vertical banded gastroplasty in obese women.
Diabetes, obesity & metabolism 1999;1(1):53-5.
1999: Mulder H; Holst L S; Svensson H; Degerman E; Sundler F; Ahrén B; Rorsman P; Holm C
Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.
Diabetes 1999;48(1):228-32.
1999: Ahrén B; Gudbjartsson T; Al-Amin A N; Mårtensson H; Myrsén-Axcrona U; Karlsson S; Mulder H; Sundler F
Islet perturbations in rats fed a high-fat diet.
Pancreas 1999;18(1):75-83.
1999: Karlsson S; Ahrén B
Cytosolic Ca2+ oscillations by gastrin releasing peptide in single HIT-T15 cells.
Peptides 1999;20(5):579-87.
1998: Ahrén B; Filipsson K
Pituitary adenylate cyclase activating polypeptide stimulates insulin secretion in a glucose-dependent manner in vivo.
Annals of the New York Academy of Sciences 1998;865():466-70.
1998: Filipsson K; Ahrén B
Protein kinase A inhibition and PACAP-induced insulin secretion in HIT-T15 cells.
Annals of the New York Academy of Sciences 1998;865():441-4.
1998: Larsson H; Elmståhl S; Berglund G; Ahrén B
Evidence for leptin regulation of food intake in humans.
The Journal of clinical endocrinology and metabolism 1998;83(12):4382-5.
1998: Filipsson K; Karlsson S; Ahrén B
Evidence for contribution by increased cytoplasmic Na+ to the insulinotropic action of PACAP38 in HIT-T15 cells.
The Journal of biological chemistry 1998;273(49):32602-7.
1998: Karlsson S; Sundler F; Ahrén B
CCK receptor subtype in insulin-producing cells: a combined functional and in situ hybridization study in rat islets and a rat insulinoma cell line.
Regulatory peptides 1998;78(1-3):95-103.
1998: Ahrén B; Oosterwijk C; Lips C J; Höppener J W
Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice.
Diabetologia 1998;41(11):1374-80.
1998: Ahrén B; Scheurink A J
Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice.
European journal of endocrinology / European Federation of Endocrine Societies 1998;139(4):461-7.
1998: Janciauskiene S; Ahrén B
Different sensitivity to the cytotoxic action of IAPP fibrils in two insulin-producing cell lines, HIT-T15 and RINm5F cells.
Biochemical and biophysical research communications 1998;251(3):888-93.
1998: Gebre-Medhin S; Mulder H; Pekny M; Westermark G; Törnell J; Westermark P; Sundler F; Ahrén B; Betsholtz C
Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).
Biochemical and biophysical research communications 1998;250(2):271-7.
1998: Ahrén B; Pacini G
Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man.
The Journal of clinical endocrinology and metabolism 1998;83(9):3350-6.
1998: Holst L S; Mulder H; Manganiello V; Sundler F; Ahrén B; Holm C; Degerman E
Protein kinase B is expressed in pancreatic beta cells and activated upon stimulation with insulin-like growth factor I.
Biochemical and biophysical research communications 1998;250(1):181-6.
1998: Simonsson E; Karlsson S; Ahrén B
Ca2+-independent phospholipase A2 contributes to the insulinotropic action of cholecystokinin-8 in rat islets: dissociation from the mechanism of carbachol.
Diabetes 1998;47(9):1436-43.
1998: Ahrén B
Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
BioEssays : news and reviews in molecular, cellular and developmental biology 1998;20(8):642-51.
1998: Larsson H; Ahrén B
Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine.
Diabetologia 1998;41(7):772-7.
1998: Filipsson K; Sundler F; Hannibal J; Ahrén B
PACAP and PACAP receptors in insulin producing tissues: localization and effects.
Regulatory peptides 1998;74(2-3):167-75.
1998: Simonsson E; Ahrén B
Potentiated beta-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice.
European journal of pharmacology 1998;350(2-3):243-50.
1998: Filipsson K; Pacini G; Scheurink A J; Ahrén B
PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice.
The American journal of physiology 1998;274(5 Pt 1):E834-42.
1998: Lindskog S; Hermansen K; Ahrén B
Effect of 3-O-methylglucose on insulin secretion in the perfused dog and rat pancreas.
Pancreas 1998;16(4):511-4.
1998: Florén C H; Ahrén B; Bengtsson M; Bartosik J; Obrant K
Bone mineral density in patients with Crohn's disease during long-term treatment with azathioprine.
Journal of internal medicine 1998;243(2):123-6.
1998: Karlsson S; Ahrén B
Insulin and glucagon secretion by ganglionic nicotinic activation in adrenalectomized mice.
European journal of pharmacology 1998;342(2-3):291-5.
1998: Karlsson S; Sundler F; Ahrén B
Insulin secretion by gastrin-releasing peptide in mice: ganglionic versus direct islet effect.
The American journal of physiology 1998;274(1 Pt 1):E124-9.
1997: Ahrén B; Larsson H
Leptin--a regulator of islet function?: its plasma levels correlate with glucagon and insulin secretion in healthy women.
Metabolism: clinical and experimental 1997;46(12):1477-81.
1997: Ahrén B; Gutniak M
No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(6):643-9.
1997: Ahrén B; Pacini G
Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance.
The American journal of physiology 1997;273(4 Pt 1):E701-7.
1997: Filipsson K; Tornøe K; Holst J; Ahrén B
Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans.
The Journal of clinical endocrinology and metabolism 1997;82(9):3093-8.
1997: Larsson H; Holst J J; Ahrén B
Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans.
Acta physiologica Scandinavica 1997;160(4):413-22.
1997: Ahrén B; Larsson H; Holst J J
Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(2):127-31.
1997: Ahrén B; Månsson S; Gingerich R L; Havel P J
Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting.
The American journal of physiology 1997;273(1 Pt 2):R113-20.
1997: Janciauskiene S; Eriksson S; Carlemalm E; Ahrén B
B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro.
Biochemical and biophysical research communications 1997;236(3):580-5.
1997: Ahrén B; Larsson H; Holst J J
Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1997;82(2):473-8.
1997: Ahrén B; Simonsson E; Scheurink A J; Mulder H; Myrsén U; Sundler F
Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice.
Metabolism: clinical and experimental 1997;46(1):97-106.
1996: Ahrén B; Larsson H
Plasma neuropeptide Y in impaired glucose tolerance.
Acta diabetologica 1996;33(4):295-7.
1996: af Klinteberg K; Karlsson S; Moller K; Sundler F; Ahrén B
Pituitary adenylate cyclase-activating polypeptide (PACAP) and insulin secretion: effects and mechanisms.
Annals of the New York Academy of Sciences 1996;805():543-8.
1996: Larsson H; Ahrén B
Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women.
The Journal of clinical endocrinology and metabolism 1996;81(12):4428-32.
1996: Larsson H; Ahrén B
Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women.
Diabetes care 1996;19(12):1399-403.
1996: Larsson H; Elmståhl S; Ahrén B
Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women.
Diabetes 1996;45(11):1580-4.
1996: Myrsén U; Ahrén B; Sundler F
Dexamethasone-induced neuropeptide Y expression in rat islet endocrine cells. Rapid reversibility and partial prevention by insulin.
Diabetes 1996;45(10):1306-16.
1996: Simonsson E; Karlsson S; Ahrén B
Involvement of phospholipase A2 and arachidonic acid in cholecystokinin-8-induced insulin secretion in rat islets.
Regulatory peptides 1996;65(2):101-7.
1996: Larsson H; Ahrén B
Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance.
Diabetologia 1996;39(9):1099-107.
1996: Ahrén B; Bertrand G; Roye M; Ribes G
Pancreastatin modulates glucose-stimulated insulin secretion from the perfused rat pancreas.
Acta physiologica Scandinavica 1996;158(1):63-70.
1996: Ahrén B; Simonsson E; Karlsson S
Glucagon-like peptide-1(7-36)amide and cytoplasmic calcium in insulin producing cells.
Acta physiologica Scandinavica 1996;157(3):333-41.
1996: Klinteberg K A; Karlsson S; Ahrén B
Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells.
Endocrinology 1996;137(7):2791-8.
1996: Leifsson B G; Ahrén B
Serum calcium and survival in a large health screening program.
The Journal of clinical endocrinology and metabolism 1996;81(6):2149-53.
1996: Karlsson S; Ahrén B
A role for islet peptide YY in the regulation of insulin secretion.
Acta physiologica Scandinavica 1996;157(2):305-6.
1996: Ahrén B; Sundkvist G; Mulder H; Sundler F
Blockade of muscarinic transmission increases the frequency of diabetes after low-dose alloxan challenge in the mouse.
Diabetologia 1996;39(4):383-90.
1996: Ahrén B
Galanin increases cytoplasmic calcium in insulin-producing RINm5F cells by activating phospholipase C.
Biochemical and biophysical research communications 1996;221(1):89-94.
1996: Larsson H; Ahrén B
Islet dysfunction in obese women with impaired glucose tolerance.
Metabolism: clinical and experimental 1996;45(4):502-9.
1996: Gregersen S; Ahrén B
Studies on the mechanisms by which gastrin releasing peptide potentiates glucose-induced insulin secretion from mouse islets.
Pancreas 1996;12(1):48-57.
1996: Karlsson S; Ahrén B
Gastrin-releasing peptide mobilizes calcium from intracellular stores in HIT-T15 cells.
Peptides 1996;17(6):909-16.
1995: Ahrén B; Gingerich R L; Havel P J
Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice.
Regulatory peptides 1995;59(3):297-302.
1995: Ahrén B; Stern J S; Gingerich R L; Curry D L; Havel P J
Glucagon secretory response to hypoglycaemia, adrenaline and carbachol in streptozotocin-diabetic rats.
Acta physiologica Scandinavica 1995;155(2):215-21.
1995: Lindskog S; Gregersen S; Hermansen K; Ahrén B
Effects of galanin on proinsulin mRNA and insulin biosynthesis in normal islets.
Regulatory peptides 1995;58(3):135-9.
1995: Ahrén B; Lindskog S; van Dijk G; Scheurink A J; Steffens A B
Effects of GLP-1 and 2,5-anhydro-D-mannitol on insulin secretion and plasma glucose in mice.
Endocrine research 1995;21(3):583-94.
1995: Larsson H; Ahrén B
Effects of arginine on the secretion of insulin and islet amyloid polypeptide in humans.
Pancreas 1995;11(2):201-5.
1995: Larsson H; Berglund G; Ahrén B
Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance.
The Journal of clinical endocrinology and metabolism 1995;80(6):1778-82.
1995: Ahrén B; Karlsson S; Scheurink A J; Steffens A B
Involvement of nitric oxide in neuroglycopenia-induced insulin and glucagon secretion in the mouse.
European journal of pharmacology 1995;280(1):27-35.
1995: Ahrén B; Sundkvist G
Long-term effects of alloxan in mice.
International journal of pancreatology : official journal of the International Association of Pancreatology 1995;17(2):197-201.
1995: Ahrén B
Insulinotropic action of truncated glucagon-like peptide-1 in mice.
Acta physiologica Scandinavica 1995;153(2):205-6.
1995: Ahrén B; Bergenfelz A
Effects of minor increase in serum calcium on the immunoheterogeneity of parathyroid hormone in healthy subjects and in patients with primary hyperparathyroidism.
Hormone research 1995;43(6):294-9.
1994: Karlsson S; Scheurink A J; Steffens A B; Ahrén B
Involvement of capsaicin-sensitive nerves in regulation of insulin secretion and glucose tolerance in conscious mice.
The American journal of physiology 1994;267(4 Pt 2):R1071-7.
1994: Nieuwenhuizen A G; Karlsson S; Fridolf T; Ahrén B
Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets.
Diabetologia 1994;37(9):871-8.
1994: Gregersen S; Langel U; Bartfai T; Ahrén B
N-terminally elongated fragments of galanin(1-16) inhibit insulin secretion from isolated mouse islets.
Regulatory peptides 1994;53(1):31-7.
1994: Gregersen S; Langel U; Bartfai T; Ahrén B
Galanin message-associated polypeptide (GMAP) does not affect insulin secretion from isolated islets.
European journal of pharmacology 1994;259(1):79-82.
1993: Bartfai T; Langel U; Bedecs K; Andell S; Land T; Gregersen S; Ahrén B; Girotti P; Consolo S; Corwin R
Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(23):11287-91.
1993: Fridolf T; Ahrén B
Effects of glucagon like peptide-1(7-36) amide on the cytoplasmic Ca(2+)-concentration in rat islet cells.
Molecular and cellular endocrinology 1993;96(1-2):85-90.
1993: Fridolf T; Karlsson S; Ahrén B
Role of extracellular Na+ on CCK-8-induced insulin secretion.
Biochemical and biophysical research communications 1993;192(3):1162-8.
1993: Fridolf T; Ahrén B
Dual action of the neuropeptide galanin on the cytoplasmic free calcium concentration in RIN m5F cells.
Biochemical and biophysical research communications 1993;191(3):1224-9.
1993: Gregersen S; Lindskog S; Land T; Langel U; Bartfai T; Ahrén B
Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35.
European journal of pharmacology 1993;232(1):35-9.
1992: Bergenfelz A; Lundstedt C; Stridbeck H; Ahrén B
Large vein sampling for intact parathyroid hormone in preoperative localization of enlarged parathyroid glands.
Acta radiologica (Stockholm, Sweden : 1987) 1992;33(6):528-31.
1992: Karlsson S; Ahrén B
Effects of tacrine on insulin secretion and 86Rb+ and 45Ca++ efflux from rat pancreatic islets.
The Journal of pharmacology and experimental therapeutics 1992;263(2):494-8.
1992: Fridolf T; Sundler F; Ahrén B
Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse.
Cell and tissue research 1992;269(2):275-9.
1992: Bergenfelz A; Tennvall J; Ahrén B
Thallium-technetium subtraction scintigraphy of enlarged parathyroid glands after calcitonin stimulation of parathyroid hormone secretion.
Acta radiologica (Stockholm, Sweden : 1987) 1992;33(4):319-22.
1992: Karlsson S; Sundler F; Ahrén B
Neonatal capsaicin-treatment in mice: effects on pancreatic peptidergic nerves and 2-deoxy-D-glucose-induced insulin and glucagon secretion.
Journal of the autonomic nervous system 1992;39(1):51-9.
1992: Fridolf T; Karlsson S; Ahrén B
Effects of CCK-8 on the cytoplasmic free calcium concentration in isolated rat islet cells.
Biochemical and biophysical research communications 1992;184(2):878-82.
1992: Karlsson S; Ahrén B
CCK-8-stimulated insulin secretion in vivo is mediated by CCKA receptors.
European journal of pharmacology 1992;213(1):145-6.
1992: Lindskog S; Skoglund G; Ahrén B
Pancreastatin inhibits insulin secretion from isolated rat islets: studies on its mechanism of action.
Diabetes research (Edinburgh, Scotland) 1992;19(3):119-23.
1992: Ahrén B; Gregersen H; Amiri M S; Jensen S L
Galanin inhibits tolbutamide-stimulated insulin secretion in the perfused pig pancreas.
Diabetes research (Edinburgh, Scotland) 1992;19(2):59-62.
1992: Lindskog S; Ahrén B; Land T; Langel U; Bartfai T
The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion.
European journal of pharmacology 1992;210(2):183-8.
1992: Ahrén B; Ostenson C G; Efendic S
The intestinal peptide PEC-60 inhibits insulin secretion in the mouse and the rat.
Pancreas 1992;7(4):443-6.
1992: Lindskog S; Ahrén B
Effects of galanin and norepinephrine on insulin secretion in the mouse.
Pancreas 1992;7(6):636-41.
1991: Karlsson S; Ahrén B
Contribution of adrenergic nerves and the adrenals to 2-deoxy-D-glucose-induced insulin and glucagon secretion in the mouse.
International journal of pancreatology : official journal of the International Association of Pancreatology 1991;10(3-4):207-15.
1991: Lindskog S; Ahrén B
Studies on the mechanism by which galanin inhibits insulin secretion in islets.
European journal of pharmacology 1991;205(1):21-7.
1991: Gregersen S; Hermansen K; Langel U; Fisone G; Bartfai T; Ahrén B
Galanin-induced inhibition of insulin secretion from rat islets: effects of rat and pig galanin and galanin fragments and analogues.
European journal of pharmacology 1991;203(1):111-4.
1991: Bergenfelz A; Forsberg L; Hederström E; Ahrén B
Preoperative localization of enlarged parathyroid glands with ultrasonically guided fine needle aspiration for parathyroid hormone assay.
Acta radiologica (Stockholm, Sweden : 1987) 1991;32(5):403-5.
1991: Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S
Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
Diabetes research and clinical practice 1991;13(3):153-61.
1991: Karlsson S; Ahrén B
CCKA receptor antagonism inhibits mechanisms underlying CCK-8-stimulated insulin release in isolated rat islets.
European journal of pharmacology 1991;202(2):253-7.
1991: Sjövall S; Foss A; Audisio R; Ahrén B; Bengmark S
Mitomycin C and lipiodol do not improve the effect of intermittent hepatic artery occlusion on liver tumour growth. An experimental study in the rat.
Anticancer research 1991;11(5):1823-5.
1991: Fridolf T; Ahrén B
GLP-1(7-36)amide-stimulated insulin secretion in rat islets is sodium-dependent.
Biochemical and biophysical research communications 1991;179(1):701-6.
1991: Karlsson S; Ahrén B
Cholecystokinin-stimulated insulin secretion and protein kinase C in rat pancreatic islets.
Acta physiologica Scandinavica 1991;142(3):397-403.
1991: Ahrén B; Ostenson C G; Mårtensson H; Efendic S
Pancreatic release of pancreastatin in the pig.
Pancreas 1991;6(3):324-9.
1991: Ahrén B; Ar'Rajab A; Böttcher G; Sundler F; Dunning B E
Presence of galanin in human pancreatic nerves and inhibition of insulin secretion from isolated human islets.
Cell and tissue research 1991;264(2):263-7.
1991: Sjövall S; Ahrén B
Hepatic dearterialisation induces glucose intolerance and inhibits insulin secretion in patients with liver malignancy.
The European journal of surgery = Acta chirurgica 1991;157(5):329-32.
1991: Fridolf T; Ahrén B
GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action.
Diabetes research (Edinburgh, Scotland) 1991;16(4):185-91.
1991: Fridolf T; Böttcher G; Sundler F; Ahrén B
GLP-1 and GLP-1(7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse.
Pancreas 1991;6(2):208-15.
1991: Karlsson S; Ahrén B
Dependence on extracellular Ca2+ for the effects of cholecystokinin-8 in rat pancreatic islets.
Diabetes research (Edinburgh, Scotland) 1991;16(3):139-43.
1991: Ahrén B; Berggren P O; Rorsman P; Ostenson C G; Efendic S
Neuropeptides in the regulation of islet hormone secretion--localization, effects and mode of action.
Advances in experimental medicine and biology 1991;291():129-42.
1990: Pettersson M; Ahrén B
Calcitonin gene-related peptide inhibits insulin secretion studies on ion fluxes and cyclic AMP in isolated rat islets.
Diabetes research (Edinburgh, Scotland) 1990;15(1):9-14.
1990: Ahrén B; Böttcher G; Kowalyk S; Dunning B E; Sundler F; Taborsky G J
Galanin is co-localized with noradrenaline and neuropeptide Y in dog pancreas and celiac ganglion.
Cell and tissue research 1990;261(1):49-58.
1990: Ahrén B; Pierzynowski S G; Weström B; Karlsson B
Pancreastatin inhibits insulin secretion and exocrine pancreatic secretion in the pig.
Diabetes research (Edinburgh, Scotland) 1990;14(2):93-6.
1990: Ahrén B; Pettersson M
Calcitonin gene-related peptide (CGRP) and amylin and the endocrine pancreas.
International journal of pancreatology : official journal of the International Association of Pancreatology 1990;6(1):1-15.
1990: Ahrén B; Karlsson S; Lindskog S
Cholinergic regulation of the endocrine pancreas.
Progress in brain research 1990;84():209-18.
1989: Ahrén B
Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse.
International journal of pancreatology : official journal of the International Association of Pancreatology 1989;5(2):165-78.
1989: Ahrén B; Skoglund G
Insulin secretion in neonatally streptozotocin-injected mice.
Diabetes research (Edinburgh, Scotland) 1989;11(4):185-9.
1989: Ahrén B; Ekman R; Laurberg P
Calcium stimulates the release of calcitonin gene-related peptide from the canine thyroid.
The American journal of physiology 1989;256(5 Pt 1):E597-9.
1989: Ahrén B
Helodermin stimulates glucagon secretion in the mouse.
Peptides 1989;10(3):709-11.
1989: Ahrén B; Böttcher G; Ekman R; Sundler F
Cysteamine and the endocrine pancreas: immunocytochemical, immunochemical, and functional aspects.
Cell and tissue research 1989;256(1):159-66.
1989: Lindskog S; Ahrén B
Effects of galanin on insulin and glucagon secretion in the rat.
International journal of pancreatology : official journal of the International Association of Pancreatology 1989;4(3):335-44.
1989: Karlsson S; Ahrén B
Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
Acta physiologica Scandinavica 1989;135(3):271-8.
1989: Ahrén B
Effects of gastrin-releasing peptide on basal and stimulated thyroid hormone secretion in the mouse.
Acta endocrinologica 1989;120(2):245-9.
1989: Ahrén B
Effects of calcitonin, katacalcin, and calcitonin gene-related peptide on basal and TSH-stimulated thyroid hormone secretion in the mouse.
Acta physiologica Scandinavica 1989;135(2):133-7.
1989: Skoglund G; Ahrén B; Lundquist I
Insulin secretion and islet lysosomal enzyme activities in the mouse. Effects of suramin.
International journal of pancreatology : official journal of the International Association of Pancreatology 1989;4(1):29-40.
1988: Skoglund G; Ahrén B; Lundquist I
Islet hormone secretion and islet lysosomal enzyme activities in the mouse: effects of chloroquine.
Diabetes research (Edinburgh, Scotland) 1988;9(3):145-9.
1988: Ahrén B
ANF inhibits glucose-stimulated insulin secretion in mouse and rat.
The American journal of physiology 1988;255(5 Pt 1):E579-82.
1988: Pettersson M; Ahrén B
Insulin and glucagon secretion in the rat: effects of gastrin releasing peptide.
Neuropeptides 1988;12(3):159-63.
1988: Ahrén B; Veith R C; Taborsky G J
The effects of epinephrine on islet hormone secretion in the dog.
International journal of pancreatology : official journal of the International Association of Pancreatology 1988;3(5):375-88.
1988: Ahrén B; Rorsman P; Berggren P O
Galanin and the endocrine pancreas.
FEBS letters 1988;229(2):233-7.
1988: Ahrén B; Taborsky G J
Effects of pancreatic noradrenaline infusion on basal and stimulated islet hormone secretion in the dog.
Acta physiologica Scandinavica 1988;132(2):143-50.
1988: Karlsson S; Ahrén B
Effects of corticotropin-releasing hormone on insulin and glucagon secretion in mice.
Acta endocrinologica 1988;117(1):87-92.
1988: Lindskog S; Ahrén B
Galanin and pancreastatin inhibit stimulated insulin secretion in the mouse: comparison of effects.
Hormone research 1988;29(5-6):237-40.
1987: Skoglund G; Lundquist I; Ahrén B
Alpha 1- and alpha 2-adrenoceptor activation increases plasma glucagon levels in the mouse.
European journal of pharmacology 1987;143(1):83-8.
1987: Pettersson M; Lundquist I; Ahrén B
Neuropeptide Y and calcitonin gene-related peptide: effects on glucagon and insulin secretion in the mouse.
Endocrine research 1987;13(4):407-17.

Sign-in to see more